Medtronic's PulseSelect PFA System Shows 98% Pulmonary Vein Isolation In Atrial Fibrillation Study
Medtronic plc (MDT) announced that clinical study results demonstrated a high rate of durable lesion formation using the PulseSelect ...
The American Journal of Managed Care1d
The Impact of FVC Decline and Lung Function in IPF
Toby Maher, MD, PhD, professor of clinical medicine, Keck Medicine of USC, discusses the impact of changes in lung function in patients with idiopathic pulmonary fibrosis (IPF).
Pulmonaryhypertensionnews.com1d
PAH therapy reverses blood vessel remodeling in preclinical model
Therapy candidate CS014 reversed remodeling of the pulmonary arteries in a preclinical model of pulmonary arterial ...
The American Journal of Managed Care1d
Combined Chemotherapy and Immunotherapy Improves Outcomes in PAH
An adult patient with pulmonary arterial hypertension (PAH) and metastatic lung adenocarcinoma showed significant clinical ...
Examining advances in endovascular therapy for stroke patients
Stroke related to large vessel occlusion (LVO) is a leading cause of disability and death worldwide. Endovascular therapy (minimally invasive procedures like catheterization done inside the blood ...
today.ucsd2d
UC San Diego Health Achieves Milestones for Lifesaving Heart and Lung Treatments
According to Madani, surgical director of the CTEPH program at UC San Diego Health, the clots in Washburn’s lungs were both ...
Managed Healthcare Executive5d
Cancer Drugs Spark Surprising Improvement in PAH Symptoms
New anecdotal evidence suggests some chemoimmunotherapy treatments may improve pulmonary arterial hypertension symptoms, but the overall evidence remains murky.